The impact of mental health and substance abuse factors on HIV prevention and treatment

Journal of Acquired Immune Deficiency Syndromes

Volumn 47, Issue SUPPL. 1, 2008, Pages

  Walkup, James ^a   Blank, Michael B ^b   Gonzalez, Jeffrey S ^c   Safren, Steven ^c,d   Schwartz, Rebecca ^e   Brown, Larry ^f   Wilson, Ira ^g   Knowlton, Amy ^h   Lombard, Frank ⁱ   Grossman, Cynthia ^j   Lyda, Karen ^k   Schumacher, Joseph E ^l  

^a RUTGERS UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d Fenway Community Health   (United States)

^e CITY UNIVERSITY OF NEW YORK   (United States)

^f BROWN UNIVERSITY   (United States)

^g TUFTS MEDICAL CENTER   (United States)

^h JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

ⁱ DUKE UNIVERSITY   (United States)

^j NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^k UNIVERSITY OF COLORADO HOSPITAL   (United States)

^l University of Alabama at Birmingham   (United States)

more..

Author keywords

Addiction; Depression; Health services; Mental illness; Substance abuse

Indexed keywords

ANTIRETROVIRUS AGENT; CANNABIS; ILLICIT DRUG; METHADONE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADDICTION; ANXIETY DISORDER; CONFERENCE PAPER; DEPRESSION; DISEASE ASSOCIATION; EMERGENCY WARD; HEALTH CARE SYSTEM; HEALTH SERVICE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL RESEARCH; MENTAL DISEASE; MENTAL HEALTH; PANIC; PATIENT COMPLIANCE; PRIORITY JOURNAL; SCHIZOPHRENIA; SEXUAL ABUSE; SUBSTANCE ABUSE;

COMMUNICABLE DISEASE CONTROL; COMORBIDITY; HEALTH BEHAVIOR; HIV INFECTIONS; HUMANS; MENTAL DISORDERS; PATIENT COMPLIANCE; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME;

EID: 40049090198     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181605b26     Document Type: Conference Paper

References (52)

1. Cournos F, McKinnon K. HIV seroprevalence among people with severe mental illness in the United States: a critical review. Clin Psychol Rev. 1997;17:259-269.
2. RachBeisel J, Scott J, Dixon LL. Co-occurring severe mental illness and substance use disorders: a review of recent research. Psychiatr Serv. 1999;50:1427-1434.
3. Klinkenberg WD, Sacks S. Mental disorders and drug abuse in persons living with HIV/AIDS. AIDS Care. 2004;16(Suppl 1):22-42.
4. Chander G, Himelhoch S, Moore RD. Substance abuse and psychiatric disorders in HIV positive patients. Drugs. 2006;66:769-789.
5. Metzger D, Navaline H. Human Immunodeficiency Virus prevention and the problems of drug abuse treatment. Clin Infect Dis. 2003;37(Suppl 5):S451-S456.
6. Bing EG, Burnam MA, Longshore D, et al. Psychiatric disorders and human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry. 2001;58:721-728.
7. Burnam MA, Bing EG, Morton SC, et al. Use of mental health and substance abuse treatment services among adults with HIV in the United States. Arch Gen Psychiatry. 2001;58:729-736.
8. Asch SM, Kilbourne AM, Gifford AL, et al. Underdiagnosis of depression in HIV. J Gen Intern Med. 2003;18:450-460.
9. Cook JA, Grey D, Burke J, et al. Depressive symptoms and AIDS-related mortality among a multisite cohort of HIV-positive women. Am J Public Health. 2004;94:1133-1140.
10. Starace F, Ammassari A, Trotta MP, et al. Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2002;31(Suppl):S136-S139.
11. Ammassari A, Murri R, Pezzotti P, et al. Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection. J Acquir Immune Defic Syndr. 2001;28:445-449.
12. Crepaz N, Marks G. Are negative affective states associated with HIV sexual risk behaviors? A meta-analytic review. Health Psychol. 2001;20:291-299.
13. Brown LK, Toulou-Shams M, Lescano C, et al. Depressive symptoms as predictors of sexual risk among African American adolescents and young adults. J Adolesc Health. 2006;39:444.e1-444.e8.
14. Williams CT, Latkin CA. The role of depressive symptoms in predicting sex with multiple and high-risk partners. J Acquir Immune Defic Syndr. 2005;38:69-73.
15. O'Leary A, Purcell D, Remien RH, et al. Childhood sexual abuse and sexual transmission risk behaviour among HIV-positive men who have sex with men. AIDS Care. 2003;15:17-26.
16. Stall R, Mills TC, Williamson J, et al. Association of co-occurring psychosocial health problems and increased vulnerability to HIV/AIDS among urban men who have sex with men. Am J Public Health. 2003;93:939-942.
17. Brief DJ, Bollinger AR, Bielhauer MJ, et al. Understanding the interface of HIV, trauma, post-traumatic stress disorder, and substance use and its implications for health outcomes. AIDS Care. 2004;16:97-120.
18. Safren SA, Knauz RO, O'Cleirigh CM, et al. CBT for adherence and depression in HIV. Presented at: Association for the Advancement of Cognitive and Behavioral Therapies; 2006; Chicago.
19. Blank M, Mandell D, Aiken L, et al. Co-occurrence of HIV and serious mental illness among Medicaid recipients. Psychiatr Serv. 2002;53:868-873.
20. Stoskopf CH, Kim YK, Glover SH. Dual diagnosis: HIV and mental illness, a population-based study. Community Ment Health J. 2001;37:469-479.
21. Walkup J, Crystal S, Sambamoorthi U. Schizophrenia and major affective disorder among Medicaid recipients with HIV/AIDS in New Jersey. Am J Public Health. 1999;89:1101-1103.
22. Meade CS, Sikkema KJ. HIV/AIDS risk among adults with severe mental illness: a systematic review. Clin Psychol Rev. 2005;25:433-457.
23. Pence BW, Miller WC, Whetten K, et al. Prevalence of DSM-IV defined mood, anxiety, and substance use disorder in an HIV clinic in the southeastern United States. J Acquir Immune Defic Syndr. 2006;42:298-306.
24. Rosenberg SD, Goodman LA, Osher F, et al. Prevalence of HIV, Hepatitis B, and Hepatitis C in people with severe mental illness. Am J Public Health. 2001;91:31-37.
25. Breyer JL, Taylor L, Gersing KR, et al. Prevalence of HIV infection in a general psychiatric outpatient population. Psychosomatics. 2007;48:31-37.
26. Himmelhoch S. Prevalence of HIV among those with serious mental illness. Presented at: Health Services Research and Development Conference; 2006; Washington.
27. Goldberg RW, Himelhoch S, Kreyenbuhl J, et al. Predictors of HIV and hepatitis testing and related service utilization among individuals with serious mental illness. Psychosomatics. 2005;46:573-577.
28. Meade CS, Sikkema KJ. Voluntary HIV testing among adults with severe mental illness: frequency and associated factors. AIDS Behav. 2005;9:465-473.
29. Walkup J, McAlpine DD, Olfson M, et al. Recent HIV testing among general hospital inpatients with schizophrenia: findings from four New York City sites. Psychiatr Q. 2000;71:177-193.
30. Pirl WF, Greer JA, Weissquarber C, et al. Screening for infectious diseases among patients in a state psychiatric hospital. Psychiatr Serv. 2005;56:1614-1616.
31. Lyss S, Branson B, Kroc K, et al. Detecting unsuspected HIV infection with a rapid whole blood HIV test in an urban emergency department. J Acquir Immune Defic Syndr. 2007;44:435-442.
32. Brady K, Berry S, Gupta R, et al. Seasonal variation in undiagnosed HIV infection on the general medicine and trauma services of two urban hospitals. J Gen Intern Med. 2005;20:324-330.
33. Walkup J, Satriano J, Sadler P, et al. HIV testing policy and serious mental illness. Am J Public Health. 2002;92:1931-1939.
34. Fairfield KM, Libman H, Davis RB, et al. Delays in protease inhibitor use in clinical practice. J Gen Intern Med. 1999;14:395-401.
35. Bogart LM, Kelly JA, Catz SL, et al. Impact of medical and nonmedical factors on physician decision making for HIV/AIDS antiretroviral treatment. J Acquir Immune Defic Syndr. 2000;23:396-404.
36. Bogart LM, Catz S, Kelly JA, et al. Factors influencing physicians' judgments of adherence and treatment decisions for patients with HIV disease. Med Decis Making. 2001;21:28-36.
37. Celentano DD, Vlahov D, Cohn S, et al. Self-reported antiretroviral therapy in injection drug users. JAMA. 1998;280:544-546.
38. Himelhoch S, Powe N, Breakey W, et al. Schizophrenia, AIDS and the decision to prescribe HAART: results of a national survey of HIV clinicians. J Prev Intervent Community. 2007;33:109-120.
39. Walkup J, Sambamoorthi U, Crystal S. Incidence and consistency of antiretroviral use among HIV-infected Medicaid beneficiaries with schizophrenia. J Clin Psychiatry. 2001;62:174-178.
40. Walkup J, Sambamoorthi U, Crystal S. Use of newer antiretroviral treatments among HIV-infected medicaid beneficiaries with serious mental illness. J Clin Psychiatry. 2004;65:1180-1189.
41. Colfax G, Vittinghoff E, Husnik MJ, et al. Substance use and sexual risk: a participant and episode level analysis of a cohort of men who have sex with men. Am J Epidemiol. 2004;159:1002-1012.
42. Knowlton A, Arnsten J, Eldred L, et al. Individual, interpersonal, and structural correlates of effective HAART use among urban active injection drug users. J Acquir Immune Defic Syndr. 2006;41:486-492.
43. Wodak A, Cooney A. Do needle syringe programs reduce HIV infection among injecting drug users: a comprehensive review of the international evidence. Subst Use Misuse. 2006;41:777-813.
44. Weisner C, Schmidt LA. Expanding the frame of health services research. Hung Stud Rev. 1995;30:707-726.
45. Mellins CA. Where are the children? Presented at: Second International Conference on HIV Treatment Adherence; 2007; Jersey City.
46. Teplin LA, Elkington KS, McClelland GM, et al. Major mental disorders, substance use disorders, comorbidity, and HIV-AIDS risk behaviors in juvenile detainees. Psychiatr Serv. 2005;56:823-828.
47. Latkin CA, Forman-Hoffman V, D'Souza G, et al. Associations between medical services use and HIV risk among HIV seropositive drug users in Baltimore, MD. AIDS Care. 2004;16:901-908.
48. Himelhoch S, Moore RD, Treisman G, et al. Does the presence of a current psychiatric disorder in AIDS patients affect the initiation of antiretroviral treatment and duration of therapy? J Acquir Immune Defic Syndr. 2004;37:1457-1463.
49. Tegger M, Uldall K, Tapia K, et al. Depression treatment decreases delay in HAART initiation among depressed HIV-infected patients. Presented at: Second International Conference on HIV Treatment Adherence; 2007; Jersey City.
50. Wagner GJ, Kanouse DE, Koegel P, et al. Adherence to HIV antiretrovirals among persons with serious mental illness. AIDS Patient Care STDS. 2003;17:179-186.
51. Bogart LM, Fremont AM, Young AS, et al. Patterns of HIV care for patient with serious mental illness. AIDS Patient Care STDS. 2006;20:175-182.
52. Sullivan G, Kanouse D, Young AS, et al. Co-location of health care for adults with serious mental illness and HIV infection. Community Ment Health J. 2006;42:345-361.